Therapeutic efficacy of CEP-33779, a novel selective JAK2 inhibitor, in a mouse model of colitis-induced colorectal cancer

Molecular Cancer Therapeutics
Matthew M SeaveyPawel Dobrzanski

Abstract

Constitutively activated STAT3 and STAT5 are expressed in a wide variety of human malignancies including solid and hematopoietic cancers and often correlate with a poor prognosis and resistance to multiple therapies. Given the well established role of STAT3 in tumorigenesis, inhibition of Janus-activated kinase 2 (JAK2) activity might represent an attractive therapeutic approach. Using a mouse model of colitis-induced colorectal cancer, we show that a novel, orally active, selective JAK2 inhibitor, CEP-33779, induced regression of established colorectal tumors, reduced angiogenesis, and reduced proliferation of tumor cells. Histopathologic analysis confirmed reduced incidence of histologic-grade neoplasia by CEP-33779. Tumor regression correlated with inhibition of STAT3 and NF-κB (RelA/p65) activation in a CEP-33779 dose-dependent manner. In addition, the expression of proinflammatory, tumor-promoting cytokines interleukin (IL)-6 and IL-1β was strongly reduced upon JAK2 inhibition. The ability of CEP-33779 to suppress growth of colorectal tumors by inhibiting the IL-6/JAK2/STAT3 signaling suggests a potential therapeutic utility of JAK2 inhibitors in multiple tumors types, particularly those with a strong inflammatory component.

References

Nov 1, 1992·Gastroenterology·E LangholzV Binder
Feb 18, 2004·Nature Reviews. Cancer·Hua Yu, Richard Jove
Jul 23, 2005·Neoplasia : an International Journal for Oncology Research·Florian M CorvinusKarlheinz Friedrich
Sep 1, 2005·Clinical Reviews in Allergy & Immunology·Raja Atreya, Markus F Neurath
Dec 23, 2006·Nature Reviews. Immunology·Hua YuDrew Pardoll
Apr 27, 2007·Neoplasia : an International Journal for Oncology Research·Svetlana A TsarevaKarlheinz Friedrich
Jan 3, 2008·Cancer Cell·Sergei Grivennikov, Michael Karin
Jan 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·S E ErdmanJ G Fox
Feb 3, 2009·Cancer Cell·Jacqueline Bromberg, Timothy C Wang
Apr 1, 2009·Journal of Carcinogenesis·Takuji Tanaka
Oct 24, 2009·Nature Reviews. Cancer·Hua YuRichard Jove
Nov 10, 2009·International Journal of Colorectal Disease·Heike Knüpfer, Rainer Preiss
Mar 23, 2010·Cell·Sergei I GrivennikovMichael Karin
Jun 8, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lydia A HaileTim F Greten
Nov 23, 2010·Digestive Diseases·Jan BornscheinPeter Malfertheiner
Nov 20, 2010·Digestive Diseases·Milan Lukas
Feb 12, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Teppei MorikawaShuji Ogino
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Aug 9, 2011·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·Noor JawadSimon J Leedham

❮ Previous
Next ❯

Citations

Nov 9, 2012·International Journal of Biological Sciences·Maximilian J WaldnerMarkus F Neurath
Feb 21, 2014·Seminars in Immunology·Koji Taniguchi, Michael Karin
Oct 1, 2013·Pharmacology & Therapeutics·Xin YaoYihong Yao
Apr 12, 2014·Cancers·Jennifer L BishopAmina Zoubeidi
Jan 3, 2012·Biochemical Pharmacology·Matthew M Seavey, Pawel Dobrzanski
Feb 2, 2013·Expert Opinion on Therapeutic Patents·Brian W Dymock, Cheng Shang See
Oct 27, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Neeraj KumariAnant Narayan Bhatt
Jun 26, 2017·Seminars in Cancer Biology·Jennifer HuynhMichael Buchert
Aug 16, 2018·Frontiers in Oncology·Emira Bousoik, Hamidreza Montazeri Aliabadi
Jun 16, 2017·Bioscience Reports·Changli WuXiujuan Zhang
Apr 24, 2018·Evidence-based Complementary and Alternative Medicine : ECAM·Estefanny Ruiz GarcíaReggiani Vilela Gonçalves
Jun 6, 2018·Journal of Experimental & Clinical Cancer Research : CR·Li-Dong ZuGuo-Hui Fu
Dec 10, 2020·Expert Opinion on Drug Metabolism & Toxicology·Karima AlimOlivier Fardel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Related Papers

Cell
Sergei I GrivennikovMichael Karin
Toxicologic Pathology
Tetsuya TsukamotoMasae Tatematsu
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Tasnim Ara, Yves A Declerck
© 2022 Meta ULC. All rights reserved